The Medical City earns JCI Academic Medical Center status, tops in Certified Clinical Programs

The Medical City strengthens its position as one of the country’s foremost healthcare institutions with its recent accreditation as an Academic Medical Center from the Joint Commission International. TMC also received JCI certification for its Primary Stroke Program. These milestones make TMC the leading institution recognized for excellence in managing the nation’s top causes of death, stroke, and heart attack—through its certified Clinical Care Programs.

In 2024, TMC was reaccredited by the JCI for its hospital program, and this year, the institution was elevated as an Academic Medical Center, a distinction granted to healthcare organizations that integrate world-class clinical care with medical research and education.

Its Department of Advanced Medical Education and the Clinical and Translational Research Institute are at the forefront of this distinction. DEPAMED anchors TMC’s commitment to continuous learning by managing its residency and fellowship programs, shaping the next generation of physicians and specialists. Meanwhile, CTRI drives innovative and collaborative biomedical and clinical research to bridge discoveries from the laboratory to bedside applications, while ensuring compliance with international standards of ethical and scientific rigor.

JCI accreditation for Primary Stroke Program recognizes TMC’s leadership in providing comprehensive, time-sensitive stroke management from emergency response and diagnostics to rehabilitation and recovery. At the heart of this program is the Brain Attack Team, a specialized group of neurologists, a neurology resident, a stroke nurse, and an interventional neurosurgeon, who respond immediately to suspected stroke cases, ensuring that every patient receives rapid and coordinated care within the critical window for treatment.

With these new accreditations, TMC affirms its position as the leading hospital in the Philippines, internationally certified for two of the leading causes of mortality in the Philippines—heart attack and stroke. The institution’s Acute Myocardial Infarction Clinical Care Program received its fourth JCI certification in 2024. 

“These recognitions are not just milestones for The Medical City, but for Philippine healthcare,” said Dr. Ruben G. Kasala, EVP and CEO of The Medical City Ortigas. “They represent our vision to integrate education, research, and patient care to continuously raise the standard of what hospitals in our country can deliver.”

JCI accreditation is regarded globally as the gold standard for hospital performance, granted only to institutions that meet stringent requirements for safety, quality, and continuous improvement.

As The Medical City marks 58 years of service, these recognitions reaffirm its mission to deliver trusted, world-class care to every Filipino. They also reflect the institution’s collective pursuit of excellence, driven by quality, compassion, and innovation across its entire network.

“For me, it’s not just about the certificates; it’s really about investing in quality care and upholding international standards for our patients,” said Dr. Stuart Bennett, president and group CEO of The Medical City. “That’s why, my aim, at least for the next year or the year after, is to achieve enterprise-wide JCI accreditations,” he continued.

For more information about The Medical City’s services, visit www.themedicalcity.com.

* * *

Editor’s Note: This article was provided by The Medical City.